Literature DB >> 16246062

Inhibition of pro-inflammatory cytokine receptor signalling by cAMP in vascular endothelial cells.

W A Sands1, T M Palmer.   

Abstract

The anti-inflammatory effects of the prototypical second messenger cAMP have been extensively documented in multiple cell types. However, in many instances, the molecular mechanisms by which cAMP elevation disrupts specific pro-inflammatory signalling cascades are unknown. In this review, we will describe the importance of the JAK-STAT (where JAK stands for Janus kinase and STAT for signal transducer and activator of transcription) signalling pathway in vascular endothelial cell function, outline key inhibitory processes that serve to reduce cytokine-stimulated tyrosine phosphorylation and activation of STAT proteins, and discuss possible mechanisms by which intracellular cAMP sensors could interact with these inhibitory processes to diminish cytokine receptor-mediated pro-inflammatory signalling.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16246062     DOI: 10.1042/BST20051126

Source DB:  PubMed          Journal:  Biochem Soc Trans        ISSN: 0300-5127            Impact factor:   5.407


  3 in total

1.  Anti-inflammatory action of exendin-4 in human islets is enhanced by phosphodiesterase inhibitors: potential therapeutic benefits in diabetic patients.

Authors:  U Pugazhenthi; K Velmurugan; A Tran; G Mahaffey; S Pugazhenthi
Journal:  Diabetologia       Date:  2010-07-16       Impact factor: 10.122

2.  EPAC1 regulates endothelial annexin A2 cell surface translocation and plasminogen activation.

Authors:  Wenli Yang; Fang C Mei; Xiaodong Cheng
Journal:  FASEB J       Date:  2018-01-05       Impact factor: 5.191

3.  The pro-resolving lipid mediator maresin 1 (MaR1) attenuates inflammatory signaling pathways in vascular smooth muscle and endothelial cells.

Authors:  Anuran Chatterjee; Anjali Sharma; Mian Chen; Robert Toy; Giorgio Mottola; Michael S Conte
Journal:  PLoS One       Date:  2014-11-19       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.